Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1975-2-27
pubmed:abstractText
Digitalis is known to have a vasoconstrictor effect in the coronary circulation. Recent studies have demonstrated that the coronary vasoconstrictor effects of acetylstrophanthidin and digoxin are neurally mediated via alpha adrenergic fibers. In the present study, experiments were done in 20 dogs anesthetized with chloralose and urethane to study the central nervous system as a possible site of action for this vasoconstrictor effect of digoxin. After the intravenous administration of 1.0 mg digoxin, cerebrospinal fluid concentrations of digoxin rose to a peak of 2.3+/-0.4 (SEM) ng/ml at 15 min, temporally corresponding to the peak in coronary vascular resistance change of +20.0+/-2.5% of control in the paced canine heart. Submicrogram digoxin injections into the lateral cerebral ventricle produced a significant increase in coronary vascular resistance, the latter injection producing a peak increase in coronary vascular resistance of 12.4+/-1.2% of control. Cross-perfusion experiments, where the isolated head of the operative dog was perfused from a donor dog receiving digoxin, thus keeping digoxin levels in the remainder of the operative dog very low, showed a similar degree of coronary vasoconstriction. Thus, the central nervous system appears to be an important site of action for the early coronary vasoconstrictor effect of digoxin.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-13199251, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-14135505, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-14259352, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-14274810, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-14289152, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-14439150, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-14777836, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-14953540, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-4393195, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-4400704, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-4402639, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-4808642, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-4872325, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-5357764, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-5388455, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-5480861, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-5551895, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-5568817, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-5662575, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-5805981, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-5820455, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-5821218, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-5824612, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-6016779, http://linkedlifedata.com/resource/pubmed/commentcorrection/4436438-6028857
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1365-72
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1974
pubmed:articleTitle
The central nervous system as a site of action for the coronary vasoconstrictor effect of digoxin.
pubmed:publicationType
Journal Article